X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-18 | KNSA | Tessari Eben | COO | S - Sale+OE | $21.04 | -17,000 | 102,975 | -14% | -$357,680 | |||||
| D | 2024-11-06 | KNSA | Patel Sanj K | COB, CEO | S - Sale+OE | $23.00 | -89,561 | 189,346 | -32% | -$2,059,903 | |||||
| D | 2024-10-15 | KNSA | Tessari Eben | COO | S - Sale+OE | $26.87 | -17,000 | 109,975 | -13% | -$456,790 | |||||
| D | 2024-09-23 | KNSA | Tessari Eben | COO | S - Sale+OE | $24.99 | -17,500 | 116,975 | -13% | -$437,325 | |||||
| D | 2024-09-03 | KNSA | Paolini John F. | CHIEF MEDICAL OFFICER | S - Sale+OE | $26.12 | -60,692 | 52,038 | -54% | -$1,584,991 | |||||
| D | 2024-09-03 | KNSA | Moat Ross | CHIEF COMMERCIAL OFFICER | S - Sale+OE | $26.12 | -68,506 | 21,736 | -76% | -$1,789,190 | |||||
| D | 2024-08-27 | KNSA | Tessari Eben | COO | S - Sale+OE | $26.91 | -17,500 | 119,911 | -13% | -$470,925 | |||||
| D | 2024-07-23 | KNSA | Patel Sanj K | COB, CEO | S - Sale+OE | $25.65 | -136,124 | 172,807 | -44% | -$3,491,947 | |||||
| D | 2024-07-23 | KNSA | Ragosa Mark | CFO | S - Sale+OE | $24.79 | -24,248 | 19,253 | -56% | -$601,108 | |||||
| D | 2024-07-23 | KNSA | Paolini John F. | CHIEF MEDICAL OFFICER | S - Sale+OE | $26.32 | -22,000 | 47,803 | -32% | -$578,966 | |||||
2024-03-07 | KNSA | Patel Sanj K | COB, CEO | S - Sale | $21.02 | -65,012 | 162,311 | -29% | -$1,366,552 | ||||||
| M | 2024-03-04 | KNSA | Patel Sanj K | COB, CEO | S - Sale | $21.34 | -18,324 | 227,323 | -7% | -$391,056 | |||||
| D | 2024-03-01 | KNSA | Tessari Eben | COO | S - Sale+OE | $22.03 | -1,189 | 122,847 | -1% | -$26,194 | |||||
| D | 2024-03-01 | KNSA | Paolini John F. | CHIEF MEDICAL OFFICER | S - Sale+OE | $21.77 | -18,844 | 44,892 | -30% | -$410,234 | |||||
| DM | 2024-02-28 | KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | S - Sale+OE | $21.57 | -14,785 | 17,588 | -46% | -$318,881 | |||||
| D | 2024-02-27 | KNSA | Paolini John F. | CHIEF MEDICAL OFFICER | S - Sale+OE | $21.03 | -10,156 | 44,892 | -18% | -$213,581 | |||||
| D | 2024-01-03 | KNSA | Ragosa Mark | CFO | S - Sale+OE | $20.00 | -12,000 | 15,632 | -43% | -$240,000 | |||||
| D | 2024-01-02 | KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | S - Sale+OE | $19.17 | -16,670 | 17,005 | -50% | -$319,564 | |||||
| D | 2023-12-19 | KNSA | Megna Michael R | CHIEF ACCOUNTING OFFICER | S - Sale+OE | $19.13 | -9,316 | 17,005 | -35% | -$178,215 | |||||
| D | 2023-12-07 | KNSA | Paolini John F. | CHIEF MEDICAL OFFICER | S - Sale+OE | $17.65 | -28,600 | 44,892 | -39% | -$504,758 | |||||
| D | 2023-09-05 | KNSA | Paolini John F. | CHIEF MEDICAL OFFICER | S - Sale+OE | $17.53 | -400 | 44,892 | -1% | -$7,012 | |||||
| D | 2023-07-25 | KNSA | Paolini John F. | CHIEF MEDICAL OFFICER | S - Sale+OE | $19.14 | -29,000 | 41,910 | -41% | -$555,160 | |||||
| D | 2022-11-29 | KNSA | Quart Barry D | Dir | S - Sale+OE | $16.15 | -21,959 | 0 | -100% | -$354,638 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |